Reviewing RYTHM (RYM) & Its Competitors

RYTHM (NASDAQ:RYM) is one of 903 public companies in the “Pharmaceuticals” industry, but how does it contrast to its competitors? We will compare RYTHM to related businesses based on the strength of its risk, dividends, earnings, profitability, institutional ownership, valuation and analyst recommendations.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for RYTHM and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RYTHM	1	0	0	0	1.00
RYTHM Competitors	7576	13626	25428	997	2.42

As a group, “Pharmaceuticals” companies have a potential upside of 32.90%. Given RYTHM’s competitors stronger consensus rating and higher possible upside, analysts plainly believe RYTHM has less favorable growth aspects than its competitors.

Institutional and Insider Ownership

6.0% of RYTHM shares are owned by institutional investors. Comparatively, 32.6% of shares of all “Pharmaceuticals” companies are owned by institutional investors. 3.5% of RYTHM shares are owned by insiders. Comparatively, 14.1% of shares of all “Pharmaceuticals” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Risk & Volatility

RYTHM has a beta of 9.44, suggesting that its share price is 844% more volatile than the S&P 500. Comparatively, RYTHM’s competitors have a beta of -3.18, suggesting that their average share price is 418% less volatile than the S&P 500.

Earnings & Valuation

This table compares RYTHM and its competitors revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
RYTHM	$17.28 million	-$33.26 million	-2.20
RYTHM Competitors	$3.48 billion	$3.12 billion	543.71

RYTHM’s competitors have higher revenue and earnings than RYTHM. RYTHM is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares RYTHM and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
RYTHM	-6.20%	-12.57%	-2.60%
RYTHM Competitors	-2,309.62%	-222.80%	-17.20%

Summary

RYTHM competitors beat RYTHM on 9 of the 13 factors compared.

About RYTHM

Agrify Corporation develops precision hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. The company offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. It also provides associated services comprising consulting, engineering, and construction. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019. Agrify Corporation was incorporated in 2016 and is headquartered in Billerica, Massachusetts.